Skip to main content

Table 6 Recently delivered women: receipt and use of prophylactic misoprostol among community deliveries % (95% CI)

From: Scaling up interventions: findings and lessons learned from an external evaluation of Niger’s National Initiative to reduce postpartum hemorrhage

 

Phase 1:

Phase 2:

p-value

 

N = 182

N = 197

 

Received counseling on PPH

48.1 (28.7, 68.2)

35.3 (20.5, 53.5)

P = .32

Received counseling/info on misoprostol

29.6 (12.7, 54.8)

17.5 (8.1, 33.8)

P = .33

Received misoprostol at ANC visit

21.1 (10.8, 36.9)

15 (7.7, 27.3)

P = .37

 

N = 35

N = 23

 

Took misoprostol for PPH prevention (among those who received it)

96.5 (83.4, 99.4)

95.8 (65.4, 99.6)

P = .87

 

N = 33

N = 22

 

Took misoprostol appropriately

94.9 (73.7, 99.2)

70 (29.7, 92.8)

P = .07

 -Correct timing

100 (100, 100)

70 (29.7, 92.8)

P = .25

 -Correct dose

94.9 (73.7, 99.2)

86.9 (27.3, 99.1)

P = .46